Pediatric Growth Disorders: Controversies in Diagnosis and Management - Robert Rapaport

Advances in pediatric endocrinology are reshaping how clinicians understand, diagnose, and treat short stature, and this volume brings those breakthroughs into sharp focus. Blending foundational science with emerging therapeutic strategies, it offers a comprehensive and clinically actionable guide for practitioners committed to improving growth outcomes in children.

The book moves through a wide spectrum of contemporary issues, beginning with innovative non‑hGH therapies and the transformative role of artificial intelligence in growth‑disorder management. It challenges long‑standing assumptions by deconstructing the category of idiopathic short stature and provides nuanced analysis of the strengths and limitations of growth hormone stimulation testing. Readers are guided through evolving concepts of growth hormone deficiency, the unique growth trajectories of children born small for gestational age, and the expanding therapeutic landscape shaped by long‑acting growth hormone formulations. Further chapters illuminate the complexities of imprinting disorders and their diagnostic pathways, while also examining the evidence‑based use of GnRH analogues and aromatase inhibitors as adjunctive therapies during puberty. Together, these discussions create a cohesive, forward‑looking exploration of the future of growth‑disorder care.

Written for pediatric endocrinologists, general pediatricians, fellows, and researchers, Pediatric Growth Disorders: Controversies in Diagnosis and Management provides the scientific depth, diagnostic clarity, and therapeutic insight needed to navigate an era in which precision medicine and technological innovation are redefining what is possible for children with short stature.